Question 1

What specific types of cancer does this trial focus on, and do I qualify?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies clinical trial (NCT07195916). Contact the study team or your healthcare provider for specific answers.

Question 2

How does INCA036873 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies clinical trial (NCT07195916). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies clinical trial (NCT07195916). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies clinical trial (NCT07195916). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the trial in terms of tests and procedures?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies clinical trial (NCT07195916). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks or benefits I should be aware of before participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies clinical trial (NCT07195916). Contact the study team or your healthcare provider for specific answers.

What this study is about